Metraipolis › archive › dc_7d07d4a43586

LASSO-Driven Selection of Biochemical and Clinical Markers for Primary Resistance to PD-1 Inhibitors in Metastatic Melanoma — Europe PMC PMID:41010951

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41010951
DOI
10.3390/medicina61091559
License (as archived)
solo-consultazione
Archived
2026-11-10T06:43:16.470Z
SHA-256 of the archived text
6a2197de91d460b98570aa4c09157cfeef2a9ae4682a91b9f96df5811b20f26d
Stable URL of this page
https://metraipolis.com/documento/dc_7d07d4a43586

How to cite

LASSO-Driven Selection of Biochemical and Clinical Markers for Primary Resistance to PD-1 Inhibitors in Metastatic Melanoma — Europe PMC PMID:41010951 — Europe PMC (en), https://europepmc.org/article/MED/41010951 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7d07d4a43586 (Metraipolis archive dc_7d07d4a43586, sha256 6a2197de91d460b98570aa4c09157cfeef2a9ae4682a91b9f96df5811b20f26d)
BibTeX
@misc{dc7d07d4a43586,
  title = {LASSO-Driven Selection of Biochemical and Clinical Markers for Primary Resistance to PD-1 Inhibitors in Metastatic Melanoma — Europe PMC PMID:41010951},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41010951},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7d07d4a43586; sha256 6a2197de91d460b98570aa4c09157cfeef2a9ae4682a91b9f96df5811b20f26d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41010951. Agents can read the archived copy with the MCP tool read_document.